Gaudium IVF and Women Health Limited
Quick Take
- • Trading at 36.4× trailing earnings
- • Moderate ROE at 13.0%
- • Low leverage (D/E 0.16)
- • No dividend data
- • Operating margin 8.8% · Net margin 21.9%
- • Profit growth -50.00% YoY · Beta —
Latest quarter · Jun 2026
| ₹ Cr | Jun 2026 | QoQ | YoY |
|---|---|---|---|
| Revenue | 19 | -36.67% | +5.56% |
| Operating Profit | 4 | -66.67% | -20.00% |
| Net Profit | 2 | -75.00% | -33.33% |
| EPS (₹) | 0.25 | -81.34% | -35.90% |
Shareholding Pattern
| Feb 2026 | Mar 2026 | Jun 2026 | |
|---|---|---|---|
| Promoters | 71.29% | 71.29% | 71.29% |
| FIIs▼3.68 | 9.24% | 6.70% | 3.02% |
| DIIs▼0.40 | 5.11% | 2.62% | 2.22% |
| Government | 0.00% | 0.00% | 0.00% |
| Public▲4.08 | 14.36% | 19.39% | 23.47% |
| No. of Shareholders | 39,883 | 19,854 | 21,910 |
* N
| Date | Party | Type | Side | Qty | Price |
|---|---|---|---|---|---|
| 22 Apr 26 | Hrti Private Limited | Bulk deal | SELL | 5,28,813 | ₹113.55 |
| 22 Apr 26 | Hrti Private Limited | Bulk deal | BUY | 4,67,409 | ₹112.54 |
| 9 Apr 26 | Gdn Ventures Llp | Bulk deal | BUY | 10,00,000 | ₹85.84 |
| 2 Mar 26 | Kishan Gopal Mohta | Bulk deal | BUY | 7,00,000 | ₹82.01 |
| 27 Feb 26 | Gdn Investments Private Limited | Bulk deal | BUY | 20,00,000 | ₹83.30 |
| 27 Feb 26 | Minerva Emerging Opportunities Fund Limited | Bulk deal | SELL | 10,00,000 | ₹83.00 |
| 27 Feb 26 | Neomile India Opportunity Fund | Bulk deal | SELL | 15,76,910 | ₹84.89 |
| 27 Feb 26 | Param Capital | Bulk deal | BUY | 25,00,000 | ₹85.51 |
About the company
From latest AR & concallGaudium IVF and Women Health Limited provides in vitro fertilization (IVF) treatment in India. The company offers fertility and reproductive health services, including intracytoplasmic sperm injection (ICSI), intrauterine insemination (IUI), and ovulation induction; polycystic ovarian syndrome (PCOS)/ polycystic ovarian disease (PCOD); endometriosis treatment; ovulation induction; and laser assisted embryo implantation services. It also provides male infertility treatment services; egg freezing; embryo freezing; frozen embryo transfer; gynae consultation; laparoscopy for infertility; diagnostic services; and support and counselling services. In addition, the company operates hospital, in-house pharmacy; and 7 hubs (IVF centers) and 28 spokes. The company was founded in 2009 and is based in New Delhi, India.
